Clear Street’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Clear Street’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.63K	Sell	218,165 -600	-0.3%	-$13	﹤0.01%	1245
2026 Q1	$4.44K	Sell	218,765 -200	-0.1%	-$6	﹤0.01%	1010
2025 Q4	$5.69K	Sell	218,965 -600	-0.3%	-$21	﹤0.01%	819
2025 Q3	$7.73K	Sell	219,565 -200	-0.1%	-$7	﹤0.01%	700
2025 Q2	$8.99K	Buy	219,765 +74,600	+51%	+$3.95K	﹤0.01%	520
2025 Q1	$11.1K	Sell	145,165 -276	-0.2%	-$17	﹤0.01%	361
2024 Q4	$4.93K	Buy	145,441 +8,404	+6%	+$338	﹤0.01%	410
2024 Q3	$4.34K	Buy	+137,037	New	+$7.93K	﹤0.01%	477

Other funds holding SLXNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

Clear Street's SLXNW Position: Q2 2026 in Review

Clear Street reduced its Silexion Therapeutics Warrant (SLXNW) stake by 0.27% in Q2 2026, selling an estimated $13 and leaving 218,165 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Clear Street first reported a position in SLXNW in Q3 2024 and has held it in 8 quarters since. The position peaked at $11.1K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Clear Street held 218,165 shares of Silexion Therapeutics Warrant worth $6.63K as of Q2 2026.
Clear Street sold 600 Silexion Therapeutics Warrant shares in Q2 2026, an estimated $13.
Silexion Therapeutics Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1245 holding.
Clear Street first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 8 quarters since.
Clear Street's Silexion Therapeutics Warrant position peaked at $11.1K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.